A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer
Clinical trial NCT07383922 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07383922
- Sponsor
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2030-06-30
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.